Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) posted its earnings results on Thursday. The biotechnology company reported $0.36 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.11), MarketWatch Earnings reports. The business had revenue of $664.46 million during the quarter. Novozymes A/S had a return on equity of 22.64% and a net […]
Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) was the recipient of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 5,300 shares, an increase of 140.9% from the October 15th total of 2,200 shares. Based on an average daily volume of 84,800 shares, the […]
Novozymes A/S (OTCMKTS:NVZMY – Get Free Report)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $47.00 and traded as low as $43.17. Novozymes A/S shares last traded at $43.23, with a volume of 26,073 shares changing hands. Analyst Ratings Changes Separately, DNB […]
Novozymes A/S (OTCMKTS:NVZMY – Get Free Report)’s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $47.00 and traded as low as $43.17. Novozymes A/S shares last traded at $43.23, with a volume of 26,073 shares trading hands. Wall Street Analysts Forecast Growth […]
DNB Markets upgraded shares of Novozymes A/S (OTCMKTS:NVZMY – Free Report) from a hold rating to a buy rating in a research note issued to investors on Tuesday, FlyOnTheWall reports. Novozymes A/S Trading Up 0.2 % Shares of NVZMY stock opened at $41.41 on Tuesday. The firm has a market capitalization of $9.41 billion, a […]